Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 3, 2019 - The FDA approved updates to the Warnings and Precautions section of the Zytiga (abiraterone acetate) drug label.
Download PDF
Return to publications
